Gamma-aminobutyric acid type A receptor subunit alpha (GABAA receptor subunit alpha)

The Gamma-aminobutyric acid type A receptor subunit alpha is one of multiple possible alpha subunits (α1–α6) that comprise part of the pentameric GABA-A receptor, the principal chloride-selective, ligand-gated inhibitory ion channel mediating fast synaptic transmission in the mammalian central nervous system. Each functional GABA-A receptor is generally assembled from two alpha, two beta, and one gamma (or alternative) subunits, forming a central chloride-conducting channel. The alpha subunit family is essential for neurotransmitter binding, allosteric modulation (such as benzodiazepine binding), and determines much of the receptor's physiological and pharmacological diversity. GABA-A receptors play central roles in regulating neuronal excitability, mediating inhibitory neurotransmission, and are targeted by numerous clinically important sedative, anxiolytic, anesthetic, and anticonvulsant drugs. Dysregulation or mutation of alpha subunits is implicated in various CNS pathologies including epilepsy, anxiety, sleep disorders, and neurodevelopmental disorders[1][2][3][5][6][8]. Important caveats: - "Gamma-aminobutyric acid receptor subunit alpha" refers to a subunit and not a complete receptor. Most drugs and disease associations relate to the assembled GABA-A receptor with alpha subunits, not the subunit in isolation[1][2][5]. - For drug development and therapeutic applications, the relevant target is typically the GABA-A receptor containing alpha subunits, although specific alpha subtypes (e.g., α1 vs. α2) may have distinct roles and drug preferences[5][6].

Other names

Alpha subunit of GABA-A receptorGABRA (plus isoform numbers, e.g., GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6)GABA-A alpha subunitGABA-A receptor alpha subunit

Positive allosteric modulation (benzodiazepines, barbiturates, some anesthetics, neurosteroids); Direct agonism/activation (GABA, muscimol, gaboxadol); Negative allosteric modulation/inhibition (picrotoxin, bicuculline, gabazine); Channel blockade (picrotoxin)